HomeDMKPQ • OTCMKTS
add
DMK Pharmaceuticals Corp
Previous close
$0.00
Day range
$0.00 - $0.00
Market cap
13.13 USD
Avg Volume
4.52K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
MarketWatch
7 hours ago
Palantir’s stock is moving to the Nasdaq. Why investors are cheering the
move.
2.50%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | 9.06K | -99.40% |
Operating expense | 2.82M | -37.17% |
Net income | -1.39M | 68.45% |
Net profit margin | -15.32K | -5,142.93% |
Earnings per share | — | — |
EBITDA | -3.08M | 27.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.66M | 175.37% |
Total assets | 8.96M | -26.20% |
Total liabilities | 13.92M | 52.41% |
Total equity | -4.96M | — |
Shares outstanding | 10.09M | — |
Price to book | -0.00 | — |
Return on assets | -114.84% | — |
Return on capital | 97.99% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -1.39M | 68.45% |
Cash from operations | -3.74M | 50.16% |
Cash from investing | 1.77M | 126.82% |
Cash from financing | 7.96M | 2,694.18% |
Net change in cash | 5.99M | 192.84% |
Free cash flow | -1.64M | 63.74% |
About
Founded
2006
Website
Employees
12
